DNA Sequencing Market Size was valued at USD 12.29 billion in 2023 to USD 44 billion by 2031, growing at a CAGR of 17.12% in the forecast period (2024-2031). Advancements in gene technologies and the growing popularity of DNA-based diagnostics and treatments are projected to drive the demand for DNA sequencing over the coming years. Growing investments in genetic research and rising demand for personalized medicine around the world are also estimated to favor DNA sequencing demand outlook in the long run.
DNA sequencing companies should be focused on research to maximize their business scope over the coming years. Use of DNA sequencing in conjunction with other gene technologies will also create new opportunities for market players in the future. The rapidly increasing popularity of gene therapies around the world and the rising prevalence of cancer are also estimated to bolster the demand for DNA sequencing across the study period and beyond.
To Learn More About This Report, Request a Free Sample Copy - https://www.skyquestt.com/sample-request/dna-sequencing-market
Streamlining DNA Sequencing Workflow Remains a Top Priority for Companies
DNA sequencing companies are expected to focus on launching new products to improve the efficacy and productivity of DNA sequencing. Investing in research and development of novel technologies and incorporation of the same in DNA sequencing will also be a popular trend for all market players. Partnerships and collaborations will also be essential in maximizing business scope for all DNA sequencing companies. The use of artificial intelligence and machine learning can also provide some highly rewarding business opportunities for DNA sequencing companies in the long run. Targeting oncology research with DNA sequencing will offer some highly attractive returns for DNA sequencing market players in the future.
In January 2024, new DNA sequencers capable of reading around 20,000 human genomes a year were announced for launch by Ultima Genomics. This company is a new name in the DNA sequencing market and it launched its UG 100 sequencer machine that costs around USD 1.5 million.
In July 2024, around USD 277 million was raised in a venture capital funding round by Element Biosciences. The company had plans to utilize this new funding to advance its research and commercialization of new gene technologies and products in the future.
In August 2024, Zymo-Seq™ SPLAT DNA Library Kit was launched to improve DNA sequencing precision and flexibility. Zymo Research was behind the launch of this novel solution that helps researchers and laboratories streamline and improve their DNA sequencing workflows.
In February 2024, Element Biosciences and Integrated DNA Technologies (IDT) came together to strengthen their partnership and launch new products that help streamline whole genomic sequencing workflows. Most of these products were launched for the AVITI™ System from Element.
Get Customization on this Report for Specific Research Solutions: https://www.skyquestt.com/speak-with-analyst/dna-sequencing-market
DNA Sequencing Market Segmental Analysis:
Product
Consumables
Instruments
Services
Technology
Synthesis
Ion Semiconductor Sequencing
Sequencing by Ligation, Pyrosequencing
Single Molecule Real-time Sequencing
Chain Termination Sequencing
Nanopore Sequencing
Application
Biomarkers
Cancer
Diagnostics
Reproductive Health
Personalized Medicine
Forensics
Others
End User
Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics
Take Action Now: Secure Your DNA Sequencing Market Today - https://www.skyquestt.com/buy-now/dna-sequencing-market
DNA Sequencing Market Top Player’s Company Profiles
Illumina, Inc.
Thermo Fisher Scientific, Inc.
Pacific Biosciences of California Inc.
BGI Group
Oxford Nanopore Technologies Ltd.
Qiagen N.V.
F. Hoffmann-La Roche Ltd.
PerkinElmer Inc.
Agilent Technologies, Inc.
Eurofins Scientific SE
Zymo Research Corp.
Hamilton Company
Genewiz Inc.
Macrogen Inc.
DNASTAR Inc.
GENEWORLD
Bio-Rad Laboratories Inc.
BioChain Institute Inc.
Beckman Coulter Inc.
Novogene Corporation
National Investment Plans with Strong Medical Research Activity to Offer Good Returns in Long Run
Improving the workflow of DNA sequencing to enhance the productivity and accuracy of the procedure will be the major trend for all market players. Investing in countries with strong medical R&D activity will also help boost market growth in the long run. Rising use of genetic technologies to create novel diagnostic and treatment products will also continue to provide lucrative opportunities for DNA sequencing providers across the study period and beyond.
Read DNA Sequencing Market Report Today - https://www.skyquestt.com/report/dna-sequencing-market
Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/dna-sequencing-market
